Modelos pronósticos para la cirrosis hepática

by Luis Calzadilla Bertot, Eduardo Vilar Gómez, Laritza Lincheta Enriquez
Published 2011-06-01

Modelos pronósticos para la cirrosis hepática Prognostic models for hepatic cirrhosis

by Luis Calzadilla Bertot, Eduardo Vilar Gómez, Laritza Lincheta Enriquez
Published 2011-06-01

Influencia de factores epidemiológicos en la progresión de la fibrosis en la hepatitis crónica C

by Eduardo Vilar Gómez, Bienvenido Grá Oramas, Raimundo Llanio Navarro, Enrique Arús Soler
Published 2003-10-01

Bases fisiopatológicas de la insuficiencia hepática aguda Physiopathological bases of acute liver failure

by Eduardo Vilar Gómez, Bienvenido Grá Oramas, Raimundo Llanio Navarro, Enrique Arús Soler
Published 2004-08-01

Enfermedad hepática por depósitos grasos. Una perspectiva actual

by Luis Alberto Pérez Blanco, Eduardo Vilar Gómez, Yadina Martínez Pérez, Luis Calzadilla Bertot
Published 2013-01-01

Non-selective beta blocker use is associated with improved short-term survival in patients with cirrhosis referred for liver transplantation

by Taiwo Ngwa, Eric Orman, Eduardo Vilar Gomez, Raj Vuppalanchi, Chandrashekhar Kubal, Naga Chalasani, Marwan Ghabril
Published 2020-01-01

Tratamiento prolongado con interferón alfa-2b más lamivudina en pacientes con hepatitis crónica B y antígeno e positivo Prolonged treatment with alpha-2b interferon plus lamivudine...

by Eduardo Vilar Gómez, Bienvenido Grá Orama, Enrique Arús Soler, Caridad Ruenes Domech, Yudith Dávila González
Published 2007-12-01

Arterial blood pressure is closely related to ascites development in compensated HCV-related cirrhosis.

by Eduardo Vilar Gomez, Ana Torres Gonzalez, Luis Calzadilla Bertot, Ali Yasells Garcia, Yoan Sanchez Rodriguez, Yadina Martinez Perez
Published 2014-01-01

Extra-hepatic comorbidity burden significantly increases 90-day mortality in patients with cirrhosis and high model for endstage liver disease

by Scott Coppel, Karan Mathur, Burcin Ekser, Kavish R. Patidar, Eric Orman, Archita P. Desai, Eduardo Vilar-Gomez, Chandrashekhar Kubal, Naga Chalasani, Lauren Nephew, Marwan Ghabril
Published 2020-09-01

Relationship of ELF and PIIINP With Liver Histology and Response to Vitamin E or Pioglitazone in the PIVENS Trial

by Samer Gawrieh, Laura A. Wilson, Katherine P. Yates, Oscar W. Cummings, Eduardo Vilar‐Gomez, Veeral Ajmera, Kris V. Kowdley, William M. Rosenberg, James Tonascia, Naga Chalasani
Published 2021-05-01

Early predictors of outcomes of hospitalization for cirrhosis and assessment of the impact of race and ethnicity at safety-net hospitals.

by V V Pavan Kedar Mukthinuthalapati, Samuel Akinyeye, Zachary P Fricker, Moinuddin Syed, Eric S Orman, Lauren Nephew, Eduardo Vilar-Gomez, James Slaven, Naga Chalasani, Maya Balakrishnan, Michelle T Long, Bashar M Attar, Marwan Ghabril
Published 2019-01-01

Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease

by Juan Pablo Arab, Melisa Dirchwolf, Mário Reis Álvares-da-Silva, Francisco Barrera, Carlos Benítez, Marlene Castellanos-Fernandez, Graciela Castro-Narro, Norberto Chavez-Tapia, Daniela Chiodi, Helma Cotrim, Kenneth Cusi, Claudia Pinto Marques Souza de Oliveira, Javier Díaz, Eduardo Fassio, Solange Gerona, Marcos Girala, Nelia Hernandez, Sebastián Marciano, Walter Masson, Nahum Méndez-Sánchez, Nathalie Leite, Adelina Lozano, Martín Padilla, Arturo Panduro, Raymundo Paraná, Edison Parise, Marlene Perez, Jaime Poniachik, Juan Carlos Restrepo, Andrés Ruf, Marcelo Silva, Martín Tagle, Monica Tapias, Kenia Torres, Eduardo Vilar-Gomez, José Eduardo Costa Gil, Adrian Gadano, Marco Arrese
Published 2020-11-01